A detailed history of J.Safra Asset Management Corp transactions in Haemonetics Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 243 shares of HAE stock, worth $14,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares
243
Previous 174 39.66%
Holding current value
$14,419
Previous $13,000 38.46%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$71.16 - $93.38 $4,910 - $6,443
69 Added 39.66%
243 $18,000
Q3 2024

Nov 13, 2024

BUY
$72.45 - $91.58 $12,606 - $15,934
174 New
174 $13,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.05B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.